Navigation Links
Clinical Trial Demonstrates That EarlySense May Be An Effective Indicator for Respiratory Pattern Recognition
Date:1/13/2014

WALTHAM, Mass., Jan. 13, 2014 /PRNewswire/ -- EarlySense, the market leader in Proactive Patient Care Solutions, announced today the results of a small clinical trial conducted at Brigham and Women's Hospital in Boston that identifies complex respiratory patterns which were found to be correlated to patients' respiratory condition and have the potential to show when mechanical ventilation is no longer required.

"The study results show that unique, complex respiratory patterns have the potential to predict, on one hand, the patients' readiness to be separated from the ventilator, but, alternately, also the need for continued ventilatory support," said Dr. Gyorgy Frendl, MD, PhD, Director of Surgical Critical Care Research, Brigham and Women's Hospital, Assistant Professor of Anesthesia, Harvard Medical School, the Principal Investigator of the study. "For patients recently weaned from the ventilator, the appearance of these complex distress respiratory patterns indicated that they were likely to require further ventilator support:

  • Generalized disorganized respirations
  • Frequent [every 30-120 seconds] high amplitude gasping breaths
  • Periods of apnea >30 seconds

For ventilated patients, the above patterns indicated that the patient is not yet ready to be separated from the mechanical ventilator support.

"The ability to measure advanced respiratory patterns in a contact-free manner is a promising approach to improve care and keep patients safer," said Avner Halperin, CEO of EarlySense. We are honored that the EarlySense technology can determine respiratory patterns and provide clinicians with advanced tools to intervene effectively and, if required, early as evidenced in this study."

About Ea
'/>"/>

SOURCE EarlySense
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. CRLX101 Meets Primary Endpoint in Phase 2 Clinical Trial in Relapsed Ovarian Cancer
2. Seres Health Announces Interim Clinical Data for SER-109 in Recurrent C. difficile
3. Concordia Healthcare Corp. announces FDA agreement on Special Protocol Assessment for Phase 3 Clinical trial on new therapy to treat perihilar cholangiocarcinoma
4. EntreMed Files New Drug Global Clinical Trial Application For ENMD-2076 With China CFDA
5. arGEN-X Receives Two Preclinical Milestone Payments Under Collaboration With Shire
6. Kaiser Permanente-Led Team to Become Integral Part of New National Clinical Research Network
7. Rigel Will Present Clinical Product Portfolio Update at J.P. Morgan Healthcare Conference
8. Altheus Therapeutics announces completed enrollment of ZA201, a Phase 2 clinical trial of Zoenasa for distal ulcerative colitis
9. Healthcare Companies Report Conference Presentation Schedule, Stock Price Updates, and Clinical Study Results - Research Report on Medivation, Envision Healthcare, Fonar, Idera Pharma, and Neurocrine
10. Croissance Clinical Research Collaborates with Acceliant for Clinical Trial Excellence
11. BioSpecifics Technologies Corp. Announces Positive Top-line Data from Phase 2 Clinical Trial of CCH for the Treatment of Human Lipoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... Sept. 30, 2014 Aileron Therapeutics, Inc. ... Global Markets Direct,s, ,Aileron Therapeutics, Inc. - ... of the Aileron Therapeutics, Inc.,s pharmaceutical research and ... on the current therapeutic developmental pipeline of Aileron ... stages, therapeutics assessment by drug target, mechanism of ...
(Date:9/30/2014)... Sept. 30, 2014  Decision Resources Group finds that the ... , China , India ... a strong rate through 2023. Dental implant procedure volumes will grow ... awareness rises. Other key findings from Decision Resources Group,s ... market: , Dental implant penetration: Penetration of dental ...
(Date:9/30/2014)... , September 30, 2014 ... research report the "Glycobiology/Glycomics Market by Product [Enzymes ... MALDI-TOF), Kits, and Reagents], Application (Immunology, Oncology) ... to 2019", published by MarketsandMarkets, provides a ... challenges, opportunities, current market trends, and strategies ...
Breaking Medicine Technology:Aileron Therapeutics, Inc. - Product Pipeline Review - 2014 2Aileron Therapeutics, Inc. - Product Pipeline Review - 2014 3Asia Pacific Dental Implant Market Will Grow at a Strong Rate Through 2023 2Asia Pacific Dental Implant Market Will Grow at a Strong Rate Through 2023 3Glycobiology / Glycomics Market Worth $928.11 Million by 2019 2Glycobiology / Glycomics Market Worth $928.11 Million by 2019 3Glycobiology / Glycomics Market Worth $928.11 Million by 2019 4
... BALTIMORE, April 24, 2012   The University of Maryland ... Vice President of Research and Development at MedImmune ... the UM Health Sciences Research Park Corporation (RPC) ... ) "The BioPark leadership team is ...
... Simcere Pharmaceutical Group (NYSE: SCR ), a ... marketing of branded generic and proprietary pharmaceuticals in China, ... results for the first quarter ended March 31, 2012 ... in the United States. Simcere,s management will host an ...
Cached Medicine Technology:University of Maryland BioPark Announces MedImmune's Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park 2University of Maryland BioPark Announces MedImmune's Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park 3Simcere Pharmaceutical Group to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012 2
(Date:10/1/2014)... of scientists has shown that more than 80 per ... drugs. , The study found that medicines called ,JAK ... genetic mutation that is present in more than 80 ... currently used, or are in clinical trials, for diseases ... , Bowel cancer is the second-most common cancer in ...
(Date:10/1/2014)... 1, 2014 Patients with increased inflammation, including ... greatly increased risk of depression. For example, a ... hepatitis C virus infection causes depression in approximately ... more commonly known as fish oil, have a ... risk of heart disease and reducing triglyceride levels. ...
(Date:10/1/2014)... Marriagelifeinsurance.com has released a new blog post explaining ... , Senior citizens can purchase a joint life insurance ... A joint policy is cheaper, but will only pay ... Life insurance can be used to cover important funeral ... online, as the application process is simple and straightforward. ...
(Date:10/1/2014)... (PRWEB) October 01, 2014 First Warning ... abnormal circadian cellular changes throughout the body, announced the ... to better address the company’s breadth of upcoming product ... breast cancer screening technology. , “Our initial focus will ... system which detects abnormal circadian cellular changes over time,” ...
(Date:10/1/2014)... 2014 Join the more than 80 golfers ... Center’s first ever charity golf tournament to benefit Project HEAL, ... disorders who cannot afford treatment. The tournament will be held ... Mo. , The day-long event starts with 10:30 a.m. ... award dinner will begin at 5 p.m. and will include ...
Breaking Medicine News(10 mins):Health News:Eighty percent of bowel cancers halted with existing medicines 2Health News:Omega-3 fatty acids may prevent some forms of depression 2Health News:Elderly Life Insurance - Find Life Insurance for Retired Couples! 2Health News:First Warning Systems Changes Name to Cyrcadia Health to Better Reflect Core Competency and Goals of Company 2Health News:First Warning Systems Changes Name to Cyrcadia Health to Better Reflect Core Competency and Goals of Company 3Health News:First Warning Systems Changes Name to Cyrcadia Health to Better Reflect Core Competency and Goals of Company 4Health News:Project HEAL Benefit Golf Tournament Gaining Momentum 2Health News:Project HEAL Benefit Golf Tournament Gaining Momentum 3
... new drugs is a highly costly and time-consuming process. Of ... or have unwanted side effects. Now a research team led ... tiny molecular "binder" that has the potential to change this ... journal Angewandte Chemie , presents the concept of a ...
... general wards are twice as likely to die as those ... treatment of the condition, published online in the journal ... comes to appropriate investigations and treatment, the findings suggest, although ... accounted for more than a quarter of a million hospital ...
... and patient embarrassment may prevent dermatologists, internists and ... to a report in the January issue of ... JAMA/Archives journals. However, dermatologists are significantly more likely ... screenings. Skin cancer is the most frequently ...
... , MONDAY, Jan. 17 (HealthDay News) -- Patients at ... can detect the deadly skin cancer at an early stage, ... prevents some people from having a doctor examine their skin ... Archives of Dermatology . People at high risk ...
... First Nations (North American Indian) babies are linked to a ... 4 weeks to 1 year of age), according to a ... Journal ) (pre-embargo link only) http://www.cmaj.ca/embargo/cmaj100837.pdf . High ... being born above the 90th percentile relative to a fetal ...
... News) -- Cigarettes start to destroy a smoker,s DNA ... the habit causes immediate genetic damage and quickly raises ... here should serve as a stark warning to those ... author Stephen S. Hecht, from the Masonic Cancer Center ...
Cached Medicine News:Health News:Breakthrough for more efficient drug development 2Health News:Heart failure patients twice as likely to die if admitted to general wards 2Health News:Clinicians cite time, patient embarrassment as barriers to performing skin cancer exams 2Health News:Thorough Exams a Must for Those at High Risk of Skin Cancer 2Health News:Thorough Exams a Must for Those at High Risk of Skin Cancer 3Health News:High birth weight in First Nations babies linked to a higher risk of postneonatal death 2Health News:Smoking Damages DNA Within Minutes, Research Shows 2
Suture Cutters, Straight...
Suture scissor...
Threaded cannula for use with Suretac® II, sterile packs, box of 10....
The Small Oval Cannula System is designed to be the smallest oval cannula system currently available, and is utilized with the Caspari Suture Punch System. Disposable seals are available with this sy...
Medicine Products: